Sign Up
OverviewAPI
Biopharmaceutical companies like GPCR Therapeutics and Vertex Pharmaceuticals are advancing in the development of innovative disease treatments, with a focus on cancer and kidney diseases, respectively. Additionally, Rapafusyn Pharmaceuticals is pioneering non-degrading molecular glues for challenging drug targets. The FDA's upcoming decisions in the second quarter will impact various biotech companies, potentially leading to approvals for advanced therapies like CAR-T treatments and vaccines.

Ask a question